secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2021-11-12T23:59:59+00:00
Accession:  0001193125-21-328226
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics elects Lyn Baranowski to Board, grants 31,695 stock options
-----------------------------------------------------------------------------

- Lyn Baranowski elected as Director effective Nov 10, 2021; term expires at next annual meeting.
- Appointed to Compensation Committee and Nominating and Corporate Governance Committee.
- Granted options to purchase 31,695 shares of Class A common stock at $26.78 (closing price on grant date).
- Options vest over 3 years: one-third at first anniversary, then monthly installments, subject to continuous service.
- Ms. Baranowski has no arrangement with others for her election, and no material interest in transactions requiring disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/0001193125-21-328226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312521328226/d626673d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-328226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer